越南老年人中功能障碍和相关因素的流行:二次数据分析
Trang Thi Nguyen1, Long Thanh Giang2, Thu Dai Bui3
1Institute of Social and Medical Studies, Ha Noi, Vietnam nttrang@isms.org.vn.
BMJ open
|March 26, 2025
概括
在越南,功能障碍很普遍.
科学领域:
- 老年学是指老年学的学科.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 功能障碍显著影响老年人的生活质量.
- 了解功能障碍的患病率和相关因素对于开发针对老龄人口的有针对性的干预措施至关重要.
研究的目的:
- 调查功能障碍的流行,包括日常生活基本活动 (ADL) 和日常生活工具活动 (IADL) 的限制.
- 确定与越南老年人功能障碍相关的社会人口统计,健康状况,行为和社会因素.
主要方法:
- 在越南12个省份进行了横截面调查.
- 来自3183名60岁及以上的个人的数据使用Katz指数对ADL和IADL评估进行了分析.
- 使用多变量逻辑回归模型来确定相关因素.
主要成果:
- ADL限制的患病率为44.6%,IADL限制为35.2%,ADL/IADL联合限制为26.3%.
- 关键相关因素包括年龄较大,教育程度较低,财富五分位数较低,自我评估健康状况不佳,多种慢性疾病,抑郁症状,获得经济支持以及缺乏社会参与.
- 对于ADL和IADL的限制,具体因素有所不同,年龄,教育,财富,慢性疾病和抑郁症状是常见的预测因素.
结论:
- 在越南的老年人中,功能障碍非常普遍.
- 干预措施应采用多因素方法,重点是提高健康素养,管理慢性疾病和抑郁症,促进社会参与.
- 政策应解决社会经济决定因素,支持社会参与,以减轻老年人群的功能限制.
相关概念视频
01:18Factors Affecting Illness
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness, disability,...
For instance, risk factors are connected to illness, disability,...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...